Global Pulmonary Drug Delivery Devices/Systems Market Insights and Forecast to 2031

Report ID: 1565621 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pulmonary Drug Delivery Devices/Systems Product Introduction
    1.2 Market by Type
        1.2.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Metered Dose Inhalers
        1.2.3 Dry Powder Inhalers
        1.2.4 Nebulizers
        1.2.5 Accessories
    1.3 Market by Application
        1.3.1 Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals and Clinics
        1.3.3 Homecare
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pulmonary Drug Delivery Devices/Systems Sales Estimates and Forecasts 2017-2028
    2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pulmonary Drug Delivery Devices/Systems Sales by Region
        2.4.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022)
        2.4.2 Global Sales Pulmonary Drug Delivery Devices/Systems by Region (2023-2028)
    2.5 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region
        2.5.1 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022)
        2.5.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Manufacturers
        3.1.1 Global Top Pulmonary Drug Delivery Devices/Systems Manufacturers by Sales (2017-2022)
        3.1.2 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pulmonary Drug Delivery Devices/Systems in 2021
    3.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers
        3.2.1 Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pulmonary Drug Delivery Devices/Systems Revenue in 2021
    3.3 Global Pulmonary Drug Delivery Devices/Systems Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pulmonary Drug Delivery Devices/Systems Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Type
        4.1.1 Global Pulmonary Drug Delivery Devices/Systems Historical Sales by Type (2017-2022)
        4.1.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    4.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Type
        4.2.1 Global Pulmonary Drug Delivery Devices/Systems Historical Revenue by Type (2017-2022)
        4.2.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    4.3 Global Pulmonary Drug Delivery Devices/Systems Price by Type
        4.3.1 Global Pulmonary Drug Delivery Devices/Systems Price by Type (2017-2022)
        4.3.2 Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pulmonary Drug Delivery Devices/Systems Sales by Application
        5.1.1 Global Pulmonary Drug Delivery Devices/Systems Historical Sales by Application (2017-2022)
        5.1.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    5.2 Global Pulmonary Drug Delivery Devices/Systems Revenue by Application
        5.2.1 Global Pulmonary Drug Delivery Devices/Systems Historical Revenue by Application (2017-2022)
        5.2.2 Global Pulmonary Drug Delivery Devices/Systems Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    5.3 Global Pulmonary Drug Delivery Devices/Systems Price by Application
        5.3.1 Global Pulmonary Drug Delivery Devices/Systems Price by Application (2017-2022)
        5.3.2 Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pulmonary Drug Delivery Devices/Systems Market Size by Type
        6.1.1 North America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
        6.1.2 North America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
    6.2 North America Pulmonary Drug Delivery Devices/Systems Market Size by Application
        6.2.1 North America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
        6.2.2 North America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
    6.3 North America Pulmonary Drug Delivery Devices/Systems Market Size by Country
        6.3.1 North America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
        6.3.2 North America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pulmonary Drug Delivery Devices/Systems Market Size by Type
        7.1.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
        7.1.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
    7.2 Europe Pulmonary Drug Delivery Devices/Systems Market Size by Application
        7.2.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
        7.2.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
    7.3 Europe Pulmonary Drug Delivery Devices/Systems Market Size by Country
        7.3.1 Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
        7.3.2 Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size by Type
        8.1.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
    8.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size by Application
        8.2.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
    8.3 Asia Pacific Pulmonary Drug Delivery Devices/Systems Market Size by Region
        8.3.1 Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Pulmonary Drug Delivery Devices/Systems Market Size by Type
        9.1.1 Latin America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
        9.1.2 Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
    9.2 Latin America Pulmonary Drug Delivery Devices/Systems Market Size by Application
        9.2.1 Latin America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
        9.2.2 Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
    9.3 Latin America Pulmonary Drug Delivery Devices/Systems Market Size by Country
        9.3.1 Latin America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
        9.3.2 Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size by Type
        10.1.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size by Application
        10.2.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Market Size by Country
        10.3.1 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Hovione
        11.1.1 Hovione Corporation Information
        11.1.2 Hovione Overview
        11.1.3 Hovione Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Hovione Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Hovione Recent Developments
    11.2 3M Health Care
        11.2.1 3M Health Care Corporation Information
        11.2.2 3M Health Care Overview
        11.2.3 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 3M Health Care Recent Developments
    11.3 Bespak
        11.3.1 Bespak Corporation Information
        11.3.2 Bespak Overview
        11.3.3 Bespak Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Bespak Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Bespak Recent Developments
    11.4 BeyonDevices
        11.4.1 BeyonDevices Corporation Information
        11.4.2 BeyonDevices Overview
        11.4.3 BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 BeyonDevices Recent Developments
    11.5 GlaxoSmithKline
        11.5.1 GlaxoSmithKline Corporation Information
        11.5.2 GlaxoSmithKline Overview
        11.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 GlaxoSmithKline Recent Developments
    11.6 H&T Presspart
        11.6.1 H&T Presspart Corporation Information
        11.6.2 H&T Presspart Overview
        11.6.3 H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 H&T Presspart Recent Developments
    11.7 PARI Respiratory Equipment
        11.7.1 PARI Respiratory Equipment Corporation Information
        11.7.2 PARI Respiratory Equipment Overview
        11.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 PARI Respiratory Equipment Recent Developments
    11.8 Philips Respironics
        11.8.1 Philips Respironics Corporation Information
        11.8.2 Philips Respironics Overview
        11.8.3 Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Philips Respironics Recent Developments
    11.9 SHL
        11.9.1 SHL Corporation Information
        11.9.2 SHL Overview
        11.9.3 SHL Pulmonary Drug Delivery Devices/Systems Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 SHL Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 SHL Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pulmonary Drug Delivery Devices/Systems Industry Chain Analysis
    12.2 Pulmonary Drug Delivery Devices/Systems Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pulmonary Drug Delivery Devices/Systems Production Mode & Process
    12.4 Pulmonary Drug Delivery Devices/Systems Sales and Marketing
        12.4.1 Pulmonary Drug Delivery Devices/Systems Sales Channels
        12.4.2 Pulmonary Drug Delivery Devices/Systems Distributors
    12.5 Pulmonary Drug Delivery Devices/Systems Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pulmonary Drug Delivery Devices/Systems Industry Trends
    13.2 Pulmonary Drug Delivery Devices/Systems Market Drivers
    13.3 Pulmonary Drug Delivery Devices/Systems Market Challenges
    13.4 Pulmonary Drug Delivery Devices/Systems Market Restraints
14 Key Findings in The Global Pulmonary Drug Delivery Devices/Systems Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Metered Dose Inhalers
    Table 3. Major Manufacturers of Dry Powder Inhalers
    Table 4. Major Manufacturers of Nebulizers
    Table 5. Major Manufacturers of Accessories
    Table 6. Global Pulmonary Drug Delivery Devices/Systems Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Pulmonary Drug Delivery Devices/Systems Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022) & (K Units)
    Table 9. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
    Table 10. Global Pulmonary Drug Delivery Devices/Systems Sales by Region (2023-2028) & (K Units)
    Table 11. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2023-2028)
    Table 12. Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2017-2022)
    Table 14. Global Pulmonary Drug Delivery Devices/Systems Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region (2023-2028)
    Table 16. Global Pulmonary Drug Delivery Devices/Systems Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Manufacturers (2017-2022)
    Table 18. Global Pulmonary Drug Delivery Devices/Systems Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Manufacturers (2017-2022)
    Table 20. Pulmonary Drug Delivery Devices/Systems Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Pulmonary Drug Delivery Devices/Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Pulmonary Drug Delivery Devices/Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pulmonary Drug Delivery Devices/Systems as of 2021)
    Table 23. Pulmonary Drug Delivery Devices/Systems Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Pulmonary Drug Delivery Devices/Systems Product Offered
    Table 25. Date of Manufacturers Enter into Pulmonary Drug Delivery Devices/Systems Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
    Table 28. Global Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
    Table 29. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Type (2017-2022)
    Table 30. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Type (2023-2028)
    Table 31. Global Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Type (2017-2022)
    Table 34. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Type (2023-2028)
    Table 35. Pulmonary Drug Delivery Devices/Systems Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
    Table 38. Global Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
    Table 39. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Application (2017-2022)
    Table 40. Global Pulmonary Drug Delivery Devices/Systems Sales Share by Application (2023-2028)
    Table 41. Global Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Application (2017-2022)
    Table 44. Global Pulmonary Drug Delivery Devices/Systems Revenue Share by Application (2023-2028)
    Table 45. Pulmonary Drug Delivery Devices/Systems Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Pulmonary Drug Delivery Devices/Systems Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
    Table 48. North America Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
    Table 49. North America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
    Table 52. North America Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
    Table 53. North America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
    Table 56. North America Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
    Table 57. North America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
    Table 60. Europe Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
    Table 61. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
    Table 64. Europe Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
    Table 65. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
    Table 68. Europe Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
    Table 69. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Hovione Corporation Information
    Table 108. Hovione Description and Major Businesses
    Table 109. Hovione Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Hovione Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Hovione Recent Developments
    Table 112. 3M Health Care Corporation Information
    Table 113. 3M Health Care Description and Major Businesses
    Table 114. 3M Health Care Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. 3M Health Care Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. 3M Health Care Recent Developments
    Table 117. Bespak Corporation Information
    Table 118. Bespak Description and Major Businesses
    Table 119. Bespak Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Bespak Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Bespak Recent Developments
    Table 122. BeyonDevices Corporation Information
    Table 123. BeyonDevices Description and Major Businesses
    Table 124. BeyonDevices Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. BeyonDevices Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. BeyonDevices Recent Developments
    Table 127. GlaxoSmithKline Corporation Information
    Table 128. GlaxoSmithKline Description and Major Businesses
    Table 129. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. GlaxoSmithKline Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. GlaxoSmithKline Recent Developments
    Table 132. H&T Presspart Corporation Information
    Table 133. H&T Presspart Description and Major Businesses
    Table 134. H&T Presspart Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. H&T Presspart Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. H&T Presspart Recent Developments
    Table 137. PARI Respiratory Equipment Corporation Information
    Table 138. PARI Respiratory Equipment Description and Major Businesses
    Table 139. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. PARI Respiratory Equipment Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. PARI Respiratory Equipment Recent Developments
    Table 142. Philips Respironics Corporation Information
    Table 143. Philips Respironics Description and Major Businesses
    Table 144. Philips Respironics Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. Philips Respironics Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Philips Respironics Recent Developments
    Table 147. SHL Corporation Information
    Table 148. SHL Description and Major Businesses
    Table 149. SHL Pulmonary Drug Delivery Devices/Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. SHL Pulmonary Drug Delivery Devices/Systems Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. SHL Recent Developments
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Pulmonary Drug Delivery Devices/Systems Distributors List
    Table 155. Pulmonary Drug Delivery Devices/Systems Customers List
    Table 156. Pulmonary Drug Delivery Devices/Systems Market Trends
    Table 157. Pulmonary Drug Delivery Devices/Systems Market Drivers
    Table 158. Pulmonary Drug Delivery Devices/Systems Market Challenges
    Table 159. Pulmonary Drug Delivery Devices/Systems Market Restraints
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pulmonary Drug Delivery Devices/Systems Product Picture
    Figure 3. Global Pulmonary Drug Delivery Devices/Systems Market Share by Type in 2021 & 2028
    Figure 3. Metered Dose Inhalers Product Picture
    Figure 4. Dry Powder Inhalers Product Picture
    Figure 5. Nebulizers Product Picture
    Figure 6. Accessories Product Picture
    Figure 7. Global Pulmonary Drug Delivery Devices/Systems Market Share by Application in 2021 & 2028
    Figure 8. Hospitals and Clinics
    Figure 9. Homecare
    Figure 10. Pulmonary Drug Delivery Devices/Systems Report Years Considered
    Figure 11. Global Pulmonary Drug Delivery Devices/Systems Sales 2017-2028 (K Units)
    Figure 12. Global Pulmonary Drug Delivery Devices/Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Pulmonary Drug Delivery Devices/Systems Revenue 2017-2028 (US$ Million)
    Figure 14. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2017-2022)
    Figure 16. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Region (2023-2028)
    Figure 17. North America Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Pulmonary Drug Delivery Devices/Systems Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Pulmonary Drug Delivery Devices/Systems Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Pulmonary Drug Delivery Devices/Systems in the World: Market Share by Pulmonary Drug Delivery Devices/Systems Revenue in 2021
    Figure 29. Global Pulmonary Drug Delivery Devices/Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    Figure 31. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    Figure 32. Global Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    Figure 33. Global Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    Figure 34. North America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    Figure 35. North America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    Figure 36. North America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    Figure 37. North America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    Figure 38. North America Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
    Figure 39. North America Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
    Figure 40. U.S. Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    Figure 43. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    Figure 45. Europe Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
    Figure 47. Europe Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
    Figure 48. Germany Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 49. France Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Pulmonary Drug Delivery Devices/Systems Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Pulmonary Drug Delivery Devices/Systems Revenue Share by Region (2017-2028)
    Figure 59. China Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 62. India Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
    Figure 73. Latin America Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
    Figure 74. Mexico Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Pulmonary Drug Delivery Devices/Systems Revenue Share by Country (2017-2028)
    Figure 83. Turkey Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Pulmonary Drug Delivery Devices/Systems Revenue (2017-2028) & (US$ Million)
    Figure 86. Pulmonary Drug Delivery Devices/Systems Value Chain
    Figure 87. Pulmonary Drug Delivery Devices/Systems Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Frequently Asked Questions
Pulmonary Drug Delivery Devices/Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pulmonary Drug Delivery Devices/Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pulmonary Drug Delivery Devices/Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports